CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL

Charles River Laboratories International, Inc. gives this daily file a useful tension rather than a tidy headline. The latest supplied SEC 10-Q, for the period ending 2026-03-28, shows revenue from contract with customer, excluding assessed tax, of $995.8M, operating income of $119.9M, and net income attributable to parent of $-14.8M. That is the centre of the story: a company still producing substantial revenue and operating income, while the final profit line in the supplied filing is negative.

The company rail in this evidence is practical rather than promotional. The supplied 10-Q excerpts point to services and products transferred over time, product revenue, inventory, and remaining performance obligations. Product revenue is cited at $197.7M versus $186.2M in the comparative disclosure, an increase of $11.4M, or 6.1%. The same product and service evidence says roughly 50% of certain performance-obligation revenue is expected to be recognised within the next twelve months, with the rest after that during the remaining contract term.

The latest filed balance-sheet and cash facts set the scale. The 10-Q for the period ending 2026-03-28 reports assets of $7.73B, liabilities of $4.74B, stockholders' equity attributable to parent of $2.94B, cash and cash equivalents of $191.8M, net cash provided by operating activities of $41.1M, inventory net of $359.7M, an inventory decrease of $-26.0M, diluted EPS of $-0.30, and diluted weighted average shares outstanding of 49.0M. Those facts do not supply a price view, but they do show the financial base from which the equity story has to be read.

No chart route or TradingView level is supplied in the evidence, so this file does not invent one. The market mechanism here is the official source rail: the 10-Q filed on 2026-05-07, the 8-K on the same date saying Charles River issued a press release with first-quarter results for the period ended 2026-03-28, the SEC company submissions and companyfacts JSON, and the later Form 4 sequence dated 2026-06-02, 2026-06-03 and 2026-06-08.

What changed on the named news rail is filing trail, not a new product launch or fresh forecast. SEC EDGAR lists multiple CRL Form 4 filings on 2026-06-02, 2026-06-03 and 2026-06-08, and the supplied source pack includes the SEC filing index plus submissions and companyfacts JSON. The evidence does not parse the Form 4 transactions, does not supply management commentary beyond the 8-K press-release notice, and does not supply a live price move. That limit matters because the honest daily story is a filed-results and disclosure story, not a rumour story.